Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 4 › Subtitle 34 - BOARD OF PHARMACY › Chapter 10.34.35 - Infusion Pharmacy Services in an Alternate Site Care Environment › Section 10.34.35.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Alternate site care environment" means
				  the location where the patient is receiving infusion therapy other than an
				  inpatient hospital setting.
(2)
				  "Compounding worksheet" means a document or electronic record which:
(a) Specifies instructions for a specific
				  compounded parenteral medication;
(b) Documents the manufacturer's:
(i) Ingredients;
(ii) Lot numbers; and
(iii) Expiration dates; and
(c) Includes a copy of the
				  prescription label.
(3)
				  Delegated Pharmacy Act.
(a) "Delegated
				  pharmacy act" means an activity that constitutes the practice of pharmacy
				  delegated by a licensed pharmacist under Health Occupations Article, Title 12,
				  Subtitle 6B, Annotated Code of Maryland, and this chapter.
(b) "Delegated pharmacy act" does not
				  include:
(i) An act within the parameters of a
				  Drug Therapy Management contract as provided under Health Occupations Article,
				  Title 12, Subtitle 6A, Annotated Code of Maryland;
(ii) The administration of an influenza
				  vaccination in accordance with Health Occupations Article, §
													12-508, Annotated
				  Code of Maryland, or Health Occupations Article, Title 12, Annotated Code of
				  Maryland;
(iii) The delegation of a
				  pharmacy act by a pharmacy technician, pharmacy student, or pharmacy technician
				  trainee;
(iv) A pharmacy activity
				  performed by a pharmacy student in accordance with Health Occupations Article,
				  §
													12-301(b),
				  Annotated Code of Maryland;
(v) A
				  pharmacy activity performed by an applicant for a license to practice pharmacy,
				  if the applicant does not perform delegated pharmacy acts for more than 10
				  months; or
(vi) The performance of
				  other functions prohibited in regulations adopted by the Board.
(4) "End of therapy"
				  means the conclusion of parenteral infusion therapy as ordered by the
				  prescriber.
(5) "Infusion nurse"
				  means a registered nurse providing infusion therapy as defined in COMAR
				  10.27.20.02BB in
				  an alternate site environment.
(6)
				  "Infusion pharmacy" means a pharmacy that provides pharmaceutical care to
				  patients receiving parenteral therapy in an alternate site care
				  environment.
(7) "Licensed
				  authorized prescriber of record" means an individual with the authority to
				  prescribe and monitor a patient's parenteral infusion therapy for the duration
				  of the patient's infusion therapy.
(8) "Parenteral infusion access device"
				  means, but is not limited to, intravenous, subcutaneous, intrathecal, epidural,
				  or peripheral nerve catheter device through which parenteral medications may be
				  administered.
(9) "Patient care
				  plan" means an individualized care plan that reflects the patient's parenteral
				  infusion therapy pharmaceutical monitoring plan aimed at optimizing the outcome
				  of therapy while minimizing untoward effects from the medication.
(10) "Patient triage form" means a written or
				  electronic tool used by a clinician or by a registered pharmacy technician when
				  communicating with a patient, a patient's caregiver, or an infusion nurse to
				  document the patient's current status, including but not limited to, the
				  patient's response to therapy, medication changes or adverse reactions, and
				  pain level.
(11) "Permit holder"
				  means a person, corporation, or other legal entity authorized by the Board to
				  establish and operate a pharmacy.
(12) "Pharmacy technician" means an
				  individual who is registered with the Board to perform delegated pharmacy
				  acts.
(13) "Pharmacist" means an
				  individual who is licensed to practice pharmacy.
(14) "Supervision" means the on-site
				  provision of management, direction, oversight and review of tasks assigned to
				  personnel.